Latest Documents


  • 3-June-2008

    English

    List of Manufactured Nanomaterials and List of Endpoints for Phase One of the OECD Testing Programme

    OECD’s Working Party on Manufactured Nanomaterials has launched a “sponsorship programme” in which countries will share the testing of specific nanomaterials (MNs) at its 3rd meeting (November 2008). Much valuable information on the safety of MNs can be derived by testing a representative set for human health and environmental safety. In launching this “sponsorship programme” the Working Party agreed a priority list of MNs for

    Related Documents
  • 30-May-2008

    English

    Current Development and Activities on the Safety of Manufactured Nanomaterials/Nanotechnologies

    Current Developments and Activities on the Safety of Manufactured Nanomaterials (3rd Meeting of the Working Party on Manufactured Nanomaterials held on 28-30 November 2007)

    Related Documents
  • 23-April-2008

    English

    OECD working party launches safety testing of nanomaterials

    OECD member countries, as well as some non-member economies and other stakeholders, are pooling expertise and funding to test the human health and environmental safety effects of a number of nanomaterials.

    Related Documents
  • 22-February-2008

    English

    International Symposium on the Risk Assessment of Manufactured Nanomaterials

    This symposium will be held on 23rd April 2007 in Tokyo, Japan. A two-day OECD WPMN meeting - OECD Workshop on the Sponsorship Programme for the Testing of Manufactured Nanomaterials - will follow this event to discuss the sponsorship programme for the testing of manufactured nanomaterials.

    Related Documents
  • 18-February-2008

    English

    Programme of work on Manufactured Nanomaterials 2006-2008

    This Programme of Work on Manufactured Nanomaterials 2006-2008 was agreed in September 2006 September by OECD’s Chemicals Committee. To implement this work the Working Party on Manufactured Nanomaterials (WPMN) was established. The Terms of Reference for the WPMN are found in Annex II.

    Related Documents
  • 10-August-2007

    English

    Nanotechnology: implications for human health, the environment and food safety

    The conference, to be held in Dublin on 2 November 2007, will focus upon the emerging discipline of nanotoxicology and its implications to the broader nanotechnology community. Particular emphasis will be given to the food, environment and medical sectors. The conference will bring together a number of international leaders in the area of nanotoxicology and represents the first conference on this novel topic to be held in Ireland. It

    Related Documents
  • 16-May-2007

    English

    International dialogue on safety of manufactured nanomaterials

    The Royal Society organised a workshop that brought together international academic experts and members of the OECD Working Party on Manufactured Nanomaterials (WPNM). This report summarises the main issues discussed during the workshop.

    Related Documents
  • 1-December-2006

    English, , 2,675kb

    Joint Report between OECD and Allianz: Opportunities and risks of Nantoechnologies

    This article shows the possible opportunities and risks of nanotechnologies today.

    Related Documents
  • 29-November-2006

    English

    Current Developments/Activities on the safety of manufactured nanomaterials: Tour de Table at the 1st meeting fot he Working Party on Manufactured Nanomaterials, London, United Kingdom, 26-27 October 2006

    This document provides information on current/planned activities related to the safety of manufactured nanomaterials in OECD countries. Information was provided as written reports by delegations who participated in the 1st Meeting of OECD's Working Party on Manufactured Nanomaterials. 

    Related Documents
  • 26-September-2005

    English

    Workshop on the Safety of Manufactured Nanomaterials

    The main objective of the Workshop on the Safety of Manufactured Nanomaterials was to determine the “state-of–the–art” for the safety assessment of manufactured nanomaterials with a particular focus on identifying future needs for risk assessment within a regulatory context.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 > >>